Company Overview of Virionics Corporation
Virionics Corporation operates as a biotechnology company. The company offers development, marketing, and commercialization of antigen presentation platform for the prevention and treatment of infectious diseases, cancers, and inflammatory diseases in the United States. Its products include PapviRx, an human papillomavirus therapeutic vaccine for the treatment of cervical dysplasia, and metastatic cervical cancer in women; HepCVax, an hepatitis C virus vaccine (HCV) for the prevention of HCV infection, and treatment of chronic HCV diseases; and RetroVax human immunodeficiency virus (HIV) vaccine to prevent HIV infection. The company was founded in 2003 and is based in Scottsdale, Arizona.
8643 East Preserve Way
Scottsdale, AZ 85266-1320
Founded in 2003
Key Executives for Virionics Corporation
Similar Private Companies By Industry
|Cleveland Diagnostics, Inc.||United States|
|ArgentumCidalElectrics Inc.||United States|
|NanoInjection Technologies, LLC||United States|
|ArmaGen Technologies, Inc.||United States|
|Aegis Environmental Management, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Virionics Corporation, please visit www.virionics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.